These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32651586)

  • 41. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Aug; 16(703):1526-1527. PubMed ID: 32852178
    [No Abstract]   [Full Text] [Related]  

  • 42. An Effective COVID-19 Vaccine Needs to Engage T Cells.
    Sauer K; Harris T
    Front Immunol; 2020; 11():581807. PubMed ID: 33117391
    [No Abstract]   [Full Text] [Related]  

  • 43. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
    Yi C; Yi Y; Li J
    Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
    [No Abstract]   [Full Text] [Related]  

  • 44. SARS-CoV-2 vaccination-A plea for fast and coordinated action.
    Beer M; Doherr M; Osterrieder K; Pfeiffer D; Trimpert J
    Zoonoses Public Health; 2020 Nov; 67(7):840. PubMed ID: 32609415
    [No Abstract]   [Full Text] [Related]  

  • 45. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 46. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 49. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'I've never worked harder': the race to develop a COVID-19 vaccine.
    Woolston C
    Nature; 2020 Nov; 587(7833):322. PubMed ID: 33168971
    [No Abstract]   [Full Text] [Related]  

  • 51. Timely development of vaccines against SARS-CoV-2.
    Lu S
    Emerg Microbes Infect; 2020; 9(1):542-544. PubMed ID: 32148172
    [No Abstract]   [Full Text] [Related]  

  • 52. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beat COVID-19 through innovation.
    Azoulay P; Jones B
    Science; 2020 May; 368(6491):553. PubMed ID: 32381693
    [No Abstract]   [Full Text] [Related]  

  • 54. What the immune response to the coronavirus says about the prospects for a vaccine.
    Ledford H
    Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981
    [No Abstract]   [Full Text] [Related]  

  • 55. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
    Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
    van Doremalen N; Lambe T; Spencer A; Belij-Rammerstorfer S; Purushotham JN; Port JR; Avanzato VA; Bushmaker T; Flaxman A; Ulaszewska M; Feldmann F; Allen ER; Sharpe H; Schulz J; Holbrook M; Okumura A; Meade-White K; Pérez-Pérez L; Edwards NJ; Wright D; Bissett C; Gilbride C; Williamson BN; Rosenke R; Long D; Ishwarbhai A; Kailath R; Rose L; Morris S; Powers C; Lovaglio J; Hanley PW; Scott D; Saturday G; de Wit E; Gilbert SC; Munster VJ
    Nature; 2020 Oct; 586(7830):578-582. PubMed ID: 32731258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 vaccine design: the Janus face of immune enhancement.
    Hotez PJ; Corry DB; Bottazzi ME
    Nat Rev Immunol; 2020 Jun; 20(6):347-348. PubMed ID: 32346094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 and the Path to Immunity.
    Stephens DS; McElrath MJ
    JAMA; 2020 Oct; 324(13):1279-1281. PubMed ID: 32915201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.